1. Home
  2. CUE vs WPRT Comparison

CUE vs WPRT Comparison

Compare CUE & WPRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CUE
  • WPRT
  • Stock Information
  • Founded
  • CUE 2014
  • WPRT 1995
  • Country
  • CUE United States
  • WPRT Canada
  • Employees
  • CUE N/A
  • WPRT N/A
  • Industry
  • CUE Biotechnology: Pharmaceutical Preparations
  • WPRT Industrial Machinery/Components
  • Sector
  • CUE Health Care
  • WPRT Industrials
  • Exchange
  • CUE Nasdaq
  • WPRT Nasdaq
  • Market Cap
  • CUE 77.3M
  • WPRT 79.1M
  • IPO Year
  • CUE 2018
  • WPRT 1995
  • Fundamental
  • Price
  • CUE $1.31
  • WPRT $3.82
  • Analyst Decision
  • CUE Strong Buy
  • WPRT Buy
  • Analyst Count
  • CUE 5
  • WPRT 3
  • Target Price
  • CUE $5.00
  • WPRT $16.33
  • AVG Volume (30 Days)
  • CUE 406.9K
  • WPRT 88.6K
  • Earning Date
  • CUE 03-10-2025
  • WPRT 11-12-2024
  • Dividend Yield
  • CUE N/A
  • WPRT N/A
  • EPS Growth
  • CUE N/A
  • WPRT N/A
  • EPS
  • CUE N/A
  • WPRT N/A
  • Revenue
  • CUE $9,532,000.00
  • WPRT $314,357,000.00
  • Revenue This Year
  • CUE $73.11
  • WPRT N/A
  • Revenue Next Year
  • CUE $11.02
  • WPRT N/A
  • P/E Ratio
  • CUE N/A
  • WPRT N/A
  • Revenue Growth
  • CUE 149.53
  • WPRT N/A
  • 52 Week Low
  • CUE $0.45
  • WPRT $3.26
  • 52 Week High
  • CUE $2.93
  • WPRT $7.41
  • Technical
  • Relative Strength Index (RSI)
  • CUE 52.47
  • WPRT 47.55
  • Support Level
  • CUE $1.21
  • WPRT $3.67
  • Resistance Level
  • CUE $1.75
  • WPRT $4.00
  • Average True Range (ATR)
  • CUE 0.18
  • WPRT 0.21
  • MACD
  • CUE 0.00
  • WPRT 0.02
  • Stochastic Oscillator
  • CUE 45.00
  • WPRT 46.38

About CUE Cue Biopharma Inc.

Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune disease with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103 and others.

About WPRT Westport Fuel Systems Inc

Westport Fuel Systems Inc is an organization engaged in the engineering, manufacturing, and supply of alternative fuel systems and components for transportation applications. It has three operating segments; the Original Equipment Manufacturers segment-design, manufacture, and sell alternative fuel systems, components and electronics, and related engineering services, to OEMs that serve light-duty, medium-duty, and heavy-duty customers, the Independent Aftermarket segment includes IAM products, conversion kits, and components allow for the conversion of vehicles after being sold to the end-user through a network of dealers and installers, and Corporate includes public company activities, corporate oversight, financing, and capital allocation.

Share on Social Networks: